Question 1

What is ALEMTUZUMAB used for?

Accepted Answer

ALEMTUZUMAB (brand name Campath) is a Other indicated for See full prescribing information.

Question 2

How does ALEMTUZUMAB work?

Accepted Answer

ALEMTUZUMAB works through the following mechanism: 12.1 Mechanism of Action CAMPATH binds to CD52, an antigen present on the surface of B and T lymphocytes, a majority of monocytes, macrophages, NK cells, and a subpopulation of granulocytes. A proportion of bone marrow cells, including some CD34+ cells, express variable levels of CD52. The proposed mechanism of action is antibody-dependent cellular-mediated lysis following cell surface binding of CAMPATH to the leukemic cells..

Question 3

What are the most common side effects of ALEMTUZUMAB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ALEMTUZUMAB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ALEMTUZUMAB the same as Campath?

Accepted Answer

Campath is a brand name for ALEMTUZUMAB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ALEMTUZUMAB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations